BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 20028513)

  • 1. Overdiagnosis in organised mammography screening in Denmark. A comparative study.
    Jørgensen KJ; Zahl PH; Gøtzsche PC
    BMC Womens Health; 2009 Dec; 9():36. PubMed ID: 20028513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The overdiagnosis nightmare: a time for caution.
    Ciatto S
    BMC Womens Health; 2009 Dec; 9():34. PubMed ID: 20015373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overdiagnosis in screening mammography in Denmark: population based cohort study.
    Njor SH; Olsen AH; Blichert-Toft M; Schwartz W; Vejborg I; Lynge E
    BMJ; 2013 Feb; 346():f1064. PubMed ID: 23444414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results of intermediate measures from a population-based, randomized trial of mammographic screening prevalence and detection of breast carcinoma among Asian women: the Singapore Breast Screening Project.
    Ng EH; Ng FC; Tan PH; Low SC; Chiang G; Tan KP; Seow A; Emmanuel S; Tan CH; Ho GH; Ng LT; Wilde CC
    Cancer; 1998 Apr; 82(8):1521-8. PubMed ID: 9554530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of breast cancer and estimates of overdiagnosis after the initiation of a population-based mammography screening program.
    Coldman A; Phillips N
    CMAJ; 2013 Jul; 185(10):E492-8. PubMed ID: 23754101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overdiagnosis in publicly organised mammography screening programmes: systematic review of incidence trends.
    Jørgensen KJ; Gøtzsche PC
    BMJ; 2009 Jul; 339():b2587. PubMed ID: 19589821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benefit-to-harm ratio of the Danish breast cancer screening programme.
    Beau AB; Lynge E; Njor SH; Vejborg I; Lophaven SN
    Int J Cancer; 2017 Aug; 141(3):512-518. PubMed ID: 28470685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overdiagnosis in the population-based service screening programme with mammography for women aged 40 to 49 years in Sweden.
    Hellquist BN; Duffy SW; Nyström L; Jonsson H
    J Med Screen; 2012 Mar; 19(1):14-9. PubMed ID: 22355181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast Cancer Screening in Denmark: A Cohort Study of Tumor Size and Overdiagnosis.
    Jørgensen KJ; Gøtzsche PC; Kalager M; Zahl PH
    Ann Intern Med; 2017 Mar; 166(5):313-323. PubMed ID: 28114661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group.
    Lynge E
    APMIS Suppl; 1998; 83():1-44. PubMed ID: 9850674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantifying the potential problem of overdiagnosis of ductal carcinoma in situ in breast cancer screening.
    Yen MF; Tabár L; Vitak B; Smith RA; Chen HH; Duffy SW
    Eur J Cancer; 2003 Aug; 39(12):1746-54. PubMed ID: 12888370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interpreting overdiagnosis estimates in population-based mammography screening.
    de Gelder R; Heijnsdijk EA; van Ravesteyn NT; Fracheboud J; Draisma G; de Koning HJ
    Epidemiol Rev; 2011; 33(1):111-21. PubMed ID: 21709144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimates of overdiagnosis of invasive breast cancer associated with screening mammography.
    Morrell S; Barratt A; Irwig L; Howard K; Biesheuvel C; Armstrong B
    Cancer Causes Control; 2010 Feb; 21(2):275-82. PubMed ID: 19894130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overdiagnosis and overtreatment associated with breast cancer mammography screening: A simulation study with calibration to population-based data.
    Seigneurin A; Labarère J; François O; Exbrayat C; Dupouy M; Filippi M; Colonna M
    Breast; 2016 Aug; 28():60-6. PubMed ID: 27240167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An estimate of overdiagnosis 15 years after the start of mammographic screening in Florence.
    Puliti D; Zappa M; Miccinesi G; Falini P; Crocetti E; Paci E
    Eur J Cancer; 2009 Dec; 45(18):3166-71. PubMed ID: 19879130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast cancer incidence after the introduction of mammography screening: what should be expected?
    Svendsen AL; Olsen AH; von Euler-Chelpin M; Lynge E
    Cancer; 2006 May; 106(9):1883-90. PubMed ID: 16572411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in incidence of in situ and invasive breast cancer by histology type following mammography screening.
    Luke C; Priest K; Roder D
    Asian Pac J Cancer Prev; 2006; 7(1):69-74. PubMed ID: 16629519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of screening mammography among women with and without a first-degree relative with breast cancer.
    Kerlikowske K; Carney PA; Geller B; Mandelson MT; Taplin SH; Malvin K; Ernster V; Urban N; Cutter G; Rosenberg R; Ballard-Barbash R
    Ann Intern Med; 2000 Dec; 133(11):855-63. PubMed ID: 11103055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In situ breast cancer: incidence trend and organised screening programmes in Italy.
    Barchielli A; Federico M; De Lisi V; Bucchi L; Ferretti S; Paci E; Ponti A; Buiatti E
    Eur J Cancer; 2005 May; 41(7):1045-50. PubMed ID: 15862754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overdiagnosis in screening: is the increase in breast cancer incidence rates a cause for concern?
    Paci E; Warwick J; Falini P; Duffy SW
    J Med Screen; 2004; 11(1):23-7. PubMed ID: 15006110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.